This study is completed in the United States, in India, in Malaysia, .... It is testing Flexible-dose Paliperidone ER for schizophrenia.
SchizophreniaDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Effectiveness and Safety of Flexible-dose Paliperidone Extended Release may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Effectiveness and Safety of Flexible-dose Paliperidone Extended Release, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in India, in Malaysia, and in the Philippines.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateDecember 2006
Recruitment status
Completed
Enrollment listed in the registry
307
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, India, Malaysia, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT00412373
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of Flexible-dose Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00412373. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
India · 8 sites
Ahmedabad
Ahmedabad
Site status: Not listed — confirm with the team
Ahmedibad
Ahmedibad
Site status: Not listed — confirm with the team
Aurangabad
Aurangabad
Site status: Not listed — confirm with the team
Chennai
Chennai
Site status: Not listed — confirm with the team
Delhi
Delhi
Site status: Not listed — confirm with the team
Kanpur Uttarpradeh
Kanpur Uttarpradeh
Site status: Not listed — confirm with the team
Pune
Pune
Site status: Not listed — confirm with the team
Vadadora
Vadadora
Site status: Not listed — confirm with the team
Malaysia · 4 sites
Ipoh
Ipoh
Site status: Not listed — confirm with the team
Kota Kinabalu
Kota Kinabalu
Site status: Not listed — confirm with the team
Kuala Lumpur
Kuala Lumpur
Site status: Not listed — confirm with the team
Kuching
Kuching
Site status: Not listed — confirm with the team
Philippines · 4 sites
Davao City
Davao City
Site status: Not listed — confirm with the team
Mandaluyong
Mandaluyong
Site status: Not listed — confirm with the team
Manila
Manila
Site status: Not listed — confirm with the team
Pasig National Capitol Region
Pasig National Capitol Region
Site status: Not listed — confirm with the team
Romania · 6 sites
Arad
Arad
Site status: Not listed — confirm with the team
Bucharest
Bucharest
Site status: Not listed — confirm with the team
Câmpina
Câmpina
Site status: Not listed — confirm with the team
Com Gura Ocnitei
Com Gura Ocnitei
Site status: Not listed — confirm with the team
Iași
Iași
Site status: Not listed — confirm with the team
Piteşti
Piteşti
Site status: Not listed — confirm with the team
South Korea · 7 sites
Daegu
Daegu
Site status: Not listed — confirm with the team
Gyeonggi-do
Gyeonggi-do
Site status: Not listed — confirm with the team
Inchun
Inchun
Site status: Not listed — confirm with the team
Jeonju
Jeonju
Site status: Not listed — confirm with the team
Kwangiu
Kwangiu
Site status: Not listed — confirm with the team
Pusan
Pusan
Site status: Not listed — confirm with the team
Seoul
Seoul
Site status: Not listed — confirm with the team
United States · 15 sites
Cerritos
Cerritos, California
Site status: Not listed — confirm with the team
Costa Mesa
Costa Mesa, California
Site status: Not listed — confirm with the team
Garden Grove
Garden Grove, California
Site status: Not listed — confirm with the team
Huntington Beach
Huntington Beach, California
Site status: Not listed — confirm with the team
Pico Rivera
Pico Rivera, California
Site status: Not listed — confirm with the team
San Diego
San Diego, California
Site status: Not listed — confirm with the team
Aventura
Aventura, Florida
Site status: Not listed — confirm with the team
Hollywood
Hollywood, Florida
Site status: Not listed — confirm with the team
Kissimmee
Kissimmee, Florida
Site status: Not listed — confirm with the team
Leesburg
Leesburg, Florida
Site status: Not listed — confirm with the team
Oklahoma City
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Philadelphia
Philadelphia, Pennsylvania
Site status: Not listed — confirm with the team
Charleston
Charleston, South Carolina
Site status: Not listed — confirm with the team
Austin
Austin, Texas
Site status: Not listed — confirm with the team
Irving
Irving, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Placebo, Paliperidone ER. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
